The U.S. needs J.&J.’s one-shot vaccine more than ever. But the company is behind on manufacturing promises made in its Operation Warp Speed contract.
Johnson & Johnson Expects Covid Vaccine Results Soon but Lags in ProductionCarl Zimmer, Sharon LaFraniere and Noah Weiland
